Amy Early
- Hematology top 5%
- Acute Myeloid Leukemia Research 5
- Hematopoietic Stem Cell Transplantation 4
- Genetics top 10%
-
- Acute Lymphoblastic Leukemia research 7
-
- Cancer Immunotherapy and Biomarkers 5
- Neutropenia and Cancer Infections 4
- Lung Cancer Research Studies 3
-
- Advanced Breast Cancer Therapies 6
- Lung Cancer Treatments and Mutations 4
- Co-authors
- Harvey D. PreislerHarry K. SlocumAzra RazaGeorge P. BrowmanMichelle J. MarinelloMartin L. BrecherSandhya PruthiJames A. Simon
- Journals
- Journal of Clinical Oncology (6 papers)Clinical Breast Cancer (3 papers)American Journal of Hematology (2 papers)
- Partner nations
- United StatesCanadaCuba
In The Last Decade
Amy Early
29 papers receiving 563 citations
Peers
Comparison fields: 5 of 51
- Hematology 346
- Genetics 104
- Public Health, Environmental and Occupational Health 268
- Oncology 230
- Pulmonary and Respiratory Medicine 127
Countries citing papers authored by Amy Early
This map shows the geographic impact of Amy Early's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Early with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Early more than expected).
Fields of papers citing papers by Amy Early
This network shows the impact of papers produced by Amy Early. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Early. The network helps show where Amy Early may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amy Early, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 1 | |
| 9 | 2021 | 11 | |
| 10 | 2020 | 27 | |
| 11 | 2020 | 7 | |
| 12 | 2018 | 21 | |
| 13 | 2017 | 1 | |
| 14 | 2017 | 35 | |
| 15 | 2017 | 3 | |
| 16 | 2011 | 42 | |
| 17 | 1987 | 68 | |
| 18 | 1983 | 2 | |
| 19 | 1983 | 107 | |
| 20 | 1982 | 21 |
About Amy Early
Amy Early is a scholar working on Hematology, Oncology, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Genetics, having authored 29 papers that have together received 642 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (7 papers), Advanced Breast Cancer Therapies (6 papers), Acute Myeloid Leukemia Research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Neutropenia and Cancer Infections (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Hematology (346 citations), Genetics (104 citations), Public Health, Environmental and Occupational Health (268 citations), Oncology (230 citations) and Pulmonary and Respiratory Medicine (127 citations). Amy Early has collaborated with scholars based in United States, Canada and Cuba. Frequent co-authors include Harvey D. Preisler, Harry K. Slocum, Azra Raza, George P. Browman, Michelle J. Marinello, Martin L. Brecher, Sandhya Pruthi, James A. Simon, Arnold I. Freeman and Ellis Levine. Their work appears in journals such as Journal of Clinical Oncology, Clinical Breast Cancer, American Journal of Hematology, Cancer Research and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.